ArticleHaematologica2018

Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a T-cell infiltrate in the bone marrow.

Dhruv Bansal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.